Literature DB >> 19252796

Wernicke encephalopathy and Creutzfeldt-Jakob disease.

A Bertrand1, J P Brandel, Y Grignon, V Sazdovitch, D Seilhean, B Faucheux, N Privat, J L Brault, A Vital, E Uro-Coste, M Pluot, F Chapon, C A Maurage, F Letournel, H Vespignani, G Place, C F Degos, K Peoc'h, S Haïk, J J Hauw.   

Abstract

We assessed the prevalence of Wernicke encephalopathy (WE) in all 657 cases suspected of Creutzfeldt-Jakob (CJD) referred from 2001 to 2006 to the French Neuropathology Network of CJD. Clinical, biological and imaging data were reviewed when the diagnosis of WE was made at autopsy. No CJD was found in five cases suspected of sporadic CJD. In these five cases, myoclonus had been observed in four, CSF 14-3-3 protein in two. In 14 other cases, WE was combined with CJD, 13 of which were sporadic. These belonged mainly to the molecular variants of sporadic CJD associated with a long duration of disease. This stresses the necessity of remaining alert to the diagnosis of WE when CJD is suspected.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252796     DOI: 10.1007/s00415-009-5038-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  Wernicke encephalopathy-like symptoms as an early manifestation of Creutzfeldt-Jakob disease in a chronic alcoholic.

Authors:  T Nagashima; M Okawa; T Kitamoto; H Takahashi; Y Ishihara; Y Ozaki; K Nagashima
Journal:  J Neurol Sci       Date:  1999-03-01       Impact factor: 3.181

2.  Case records of the Massachusetts General Hospital. Case 27-2005. An 80-year-old man with fatigue, unsteady gait, and confusion.

Authors:  Richard T Johnson; R Gilberto Gonzalez; Matthew P Frosch
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

3.  Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.

Authors:  S J Collins; P Sanchez-Juan; C L Masters; G M Klug; C van Duijn; A Poleggi; M Pocchiari; S Almonti; N Cuadrado-Corrales; J de Pedro-Cuesta; H Budka; E Gelpi; M Glatzel; M Tolnay; E Hewer; I Zerr; U Heinemann; H A Kretszchmar; G H Jansen; E Olsen; E Mitrova; A Alpérovitch; J-P Brandel; J Mackenzie; K Murray; R G Will
Journal:  Brain       Date:  2006-07-01       Impact factor: 13.501

4.  Wernicke encephalopathy in nonalcoholic patients.

Authors:  Paul R Ogershok; Aamer Rahman; Scott Nestor; James Brick
Journal:  Am J Med Sci       Date:  2002-02       Impact factor: 2.378

5.  Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates.

Authors:  J P Brandel; N Delasnerie-Lauprêtre; J L Laplanche; J J Hauw; A Alpérovitch
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

6.  Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases).

Authors:  H Budka; A Aguzzi; P Brown; J M Brucher; O Bugiani; F Gullotta; M Haltia; J J Hauw; J W Ironside; K Jellinger
Journal:  Brain Pathol       Date:  1995-10       Impact factor: 6.508

7.  Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease.

Authors:  S Haïk; J P Brandel; V Sazdovitch; N Delasnerie-Lauprêtre; K Peoc'h; J L Laplanche; N Privat; C Duyckaerts; J L Kemeny; N Kopp; A Laquerrière; M Mohr; J P Deslys; D Dormont; J J Hauw
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

8.  Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene.

Authors:  J J Hauw; V Sazdovitch; J L Laplanche; K Peoc'h; N Kopp; J Kemeny; N Privat; N Delasnerie-Lauprêtre; J P Brandel; J P Deslys; D Dormont; A Alpérovitch
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

9.  Jakob-Creutzfeldt disease associated with Wernicke encephalopathy.

Authors:  S Gaytan-Garcia; J J Gilbert; J H Deck; J C Kaufmann
Journal:  Can J Neurol Sci       Date:  1988-05       Impact factor: 2.104

10.  Chromatolysis in alcoholic encephalopathies. Pellagra-like changes in 22 cases.

Authors:  J J Hauw; C De Baecque; C Hausser-Hauw; M Serdaru
Journal:  Brain       Date:  1988-08       Impact factor: 13.501

View more
  8 in total

1.  Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease.

Authors:  Numthip Chitravas; Richard S Jung; Diane M Kofskey; Janis E Blevins; Pierluigi Gambetti; R John Leigh; Mark L Cohen
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

2.  Elevated cerebrospinal fluid tau in Wernicke encephalopathy.

Authors:  Daphne W Frijlink; Joachim J Tilanus; Gerwin Roks
Journal:  BMJ Case Rep       Date:  2012-08-08

Review 3.  14-3-3s are potential biomarkers for HIV-related neurodegeneration.

Authors:  Diana Morales; Efthimios C M Skoulakis; Summer F Acevedo
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

4.  Basal Ganglia involvement in Wernicke encephalopathy: report of 2 cases.

Authors:  G Zuccoli; I Cravo; A Bailey; A Venturi; R Nardone
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-15       Impact factor: 3.825

Review 5.  Wernicke's encephalopathy: expanding the diagnostic toolbox.

Authors:  Mary E Lough
Journal:  Neuropsychol Rev       Date:  2012-05-11       Impact factor: 7.444

6.  Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?

Authors:  Gabor G Kovacs; Alexander Peden; Serge Weis; Romana Höftberger; Anna S Berghoff; Helen Yull; Thomas Ströbel; Stefan Koppi; Regina Katzenschlager; Dieter Langenscheidt; Hamid Assar; Elisabeth Zaruba; Albrecht Gröner; Till Voigtländer; Gina Puska; Eva Hametner; Astrid Grams; Armin Muigg; Michael Knoflach; Lajos László; James W Ironside; Mark W Head; Herbert Budka
Journal:  Acta Neuropathol Commun       Date:  2013-11-11       Impact factor: 7.801

7.  Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.

Authors:  Francesca Lattanzio; Samir Abu-Rumeileh; Alessia Franceschini; Hideaki Kai; Giulia Amore; Ilaria Poggiolini; Marcello Rossi; Simone Baiardi; Lynne McGuire; Anna Ladogana; Maurizio Pocchiari; Alison Green; Sabina Capellari; Piero Parchi
Journal:  Acta Neuropathol       Date:  2017-02-15       Impact factor: 17.088

8.  Genetic Creutzfeldt-Jakob disease shows fatal family insomnia phenotype.

Authors:  Bin Chen; Shan Zhang; Ying Xiao; Yingman Wu; Weiting Tang; Limin Yan; Zhengxue Zhang; Shengquan Qin; Mingming Dai; Yong You
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.